Raghav, K. P. S., Bando, H., Ke, T., Pelster, M., Antonuzzo, L., Spindler, K. G., Han, S., Yeh, K., Zhang, Z., Aristide, M. R. N., Yamagishi, C., Chang, H., Zhao, O., Seshadri, R., Parikh, A. R. (2026). A phase 2 randomized study comparing telisotuzumab adizutecan monotherapy with standard of care in patients with post-adjuvant circulating tumor DNA-positive colorectal cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.2_suppl.tps265